<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <title>Sodium Bicarbonate - Medications - Offline Clinical Reference</title>
  <link rel="stylesheet" href="../style.css">
</head>
<body>
  <div class="topbar">
    <div class="topbar-inner">
      <span class="pill"><strong>Sodium Bicarbonate</strong></span>
      <span class="spacer"></span>
      <div class="nav-btns">
        <a class="btn small" href="../index.html">Home</a>
        <a class="btn small" href="../medications.html">Back to Medications</a>
      </div>
    </div>
  </div>

  <main class="wrap">
    <section class="section">
      <div class="kicker">Endocrine / Metabolic / Antidotes</div>
      <h1>Sodium Bicarbonate</h1>

      <div class="content">
        <h3>Stocked on board</h3>
        <ul>
          <li>Sodium Bicarbonate 8.4% Injection 50mL</li>
        </ul>

        <div class="rule"></div>

        <h3>Adult dosing</h3>
        <ul>
          <li><strong>Cardiac arrest (advanced life support - specific indications)</strong>
            <ul>
              <li>1 mEq/kg IV (50 mL of 8.4% = 50 mEq) during resuscitation for hyperkalemia, severe metabolic acidosis, or tricyclic antidepressant overdose (per ACLS protocols)</li>
              <li>May repeat 0.5 mEq/kg every 10 minutes if indicated; follow medical direction</li>
            </ul>
          </li>
          <li><strong>Severe metabolic acidosis (non-arrest)</strong>
            <ul>
              <li>Dose depends on base deficit and clinical context; typical initial dose 50–100 mEq IV slow infusion</li>
              <li>Requires careful monitoring; consult medical direction/guidelines</li>
            </ul>
          </li>
          <li><strong>Tricyclic antidepressant (TCA) overdose with QRS widening or hypotension</strong>
            <ul>
              <li>1–2 mEq/kg IV bolus (50–100 mEq); repeat as guided by ECG/clinical response</li>
              <li>Target serum pH 7.45–7.55; requires close monitoring and medical direction</li>
            </ul>
          </li>
        </ul>

        <div class="rule"></div>

        <h3>Adverse effects</h3>
        <ul>
          <li>Metabolic alkalosis (from overcorrection)</li>
          <li>Hypernatremia, fluid overload (high sodium content)</li>
          <li>Paradoxical intracellular acidosis (rapid CO2 generation)</li>
          <li>Tissue necrosis if extravasation occurs (highly alkaline)</li>
          <li>Hypocalcemia, hypokalemia (shift effects)</li>
        </ul>

        <div class="rule"></div>

        <h3>Indications</h3>
        <ul>
          <li>Cardiac arrest with specific indications (hyperkalemia, severe pre-existing metabolic acidosis, tricyclic antidepressant overdose)</li>
          <li>Severe metabolic acidosis (pH &lt;7.1–7.2) when underlying cause is being treated</li>
          <li>Tricyclic antidepressant overdose with cardiac toxicity (QRS widening, arrhythmias, hypotension)</li>
          <li>Selected poisonings/overdoses requiring urinary alkalinization (e.g., salicylate, methotrexate)</li>
        </ul>

        <div class="rule"></div>

        <h3>Contraindications / cautions</h3>
        <ul>
          <li>Hypocalcemia, hypokalemia (can worsen with bicarbonate administration)</li>
          <li>Metabolic or respiratory alkalosis</li>
          <li>Severe pulmonary edema or fluid overload (high sodium load)</li>
          <li>Inadequate ventilation (cannot eliminate CO2 generated by bicarbonate)</li>
          <li>Caution in hypernatremia or salt-retaining states (heart failure, renal impairment)</li>
          <li>Do not mix with calcium-containing solutions (precipitation risk)</li>
        </ul>

        <div class="rule"></div>

        <h3>Preparation &amp; administration</h3>
        <ul>
          <li>8.4% solution = 1 mEq/mL (50 mL vial = 50 mEq)</li>
          <li>IV push: Give slowly (max 1 mEq/kg over 1–2 minutes in arrest; slower in non-arrest)</li>
          <li>IV infusion: Dilute in D5W or saline for slower administration when appropriate</li>
          <li>Flush line before/after; ensure secure IV access (extravasation causes tissue damage)</li>
          <li>Do not administer simultaneously with calcium or catecholamines in same IV line</li>
        </ul>

        <div class="rule"></div>

        <h3>Monitoring</h3>
        <ul>
          <li>Clinical response (hemodynamics, ECG in TCA overdose/hyperkalemia)</li>
          <li>Arterial or venous blood gas (pH, pCO2, bicarbonate) when feasible</li>
          <li>Serum electrolytes (sodium, potassium, calcium) if available</li>
          <li>IV site for extravasation (stop immediately if occurs)</li>
          <li>Ventilation adequacy (ensure patient can eliminate CO2)</li>
        </ul>

        <div class="rule"></div>

        <h3>At-sea considerations</h3>
        <ul>
          <li>High-risk medication: use only for specific indications per ACLS/toxicology protocols and medical direction</li>
          <li>In cardiac arrest: focus on high-quality CPR and defibrillation; bicarbonate is adjunct for specific scenarios only</li>
          <li>Limited lab capability: rely on clinical response (ECG changes, hemodynamics) and serial reassessment</li>
          <li>Document dose, time, indication, and response clearly for medical handover</li>
          <li>If TCA overdose suspected: consider early evacuation planning; bicarbonate is temporizing measure</li>
        </ul>

        <div class="rule"></div>

        <h3>Online-only references</h3>
        <ul>
          <li>Health Canada product monograph (sodium bicarbonate injection): <a href="https://pdf.hres.ca/dpd_pm/00067917.PDF" target="_blank" rel="noopener">https://pdf.hres.ca/dpd_pm/00067917.PDF</a></li>
          <li>American Heart Association ACLS guidelines: <a href="https://www.ahajournals.org/doi/10.1161/CIR.0000000000000916" target="_blank" rel="noopener">https://www.ahajournals.org/doi/10.1161/CIR.0000000000000916</a></li>
          <li>BC EHS Drug Monograph – Sodium Bicarbonate: <a href="https://handbook.bcehs.ca/drug-monographs/sodium-bicarbonate/" target="_blank" rel="noopener">https://handbook.bcehs.ca/drug-monographs/sodium-bicarbonate/</a></li>
        </ul>
      </div>

      <p class="foot">
        Verify dosing and indications against current clinical guidelines.
      </p>
    </section>
  </main>
</body>
</html>
